KYLA CRISPE: Open Payments
NPI 1740736099 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,924 in 188 payments from 24 companies in 2025. Trend: 2023 $3,891 · 2024 $2,244 · 2025 $10,924
Speaker / faculty: $7,275Food & beverage: $3,439Education: $210
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 22 | $7,689 |
| Novartis Pharmaceuticals Corporation | 21 | $541 |
| ABBVIE INC. | 25 | $421 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $405 |
| UCB, Inc. | 20 | $285 |
| Janssen Biotech, Inc. | 10 | $210 |
| GENZYME CORPORATION | 12 | $185 |
| Arcutis Biotherapeutics, Inc. | 12 | $180 |
| LEO Pharma Inc. | 10 | $151 |
| Regeneron Healthcare Solutions, Inc. | 9 | $142 |
Products named: NEMLUVIO, COSENTYX, DUPIXENT, ILUMYA, SKYRIZI, Bimzelx, TREMFYA, Zoryve.
Industry payments across TX — which companies pay providers there.
